Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kulikov VI and Muzya GI Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo. 2002 Biochemistry Mosc. pmid:12495421
Pawliczak R et al. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444032
MacKinnon AC et al. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. 2002 J. Immunol. pmid:12444147
Marrache AM et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. 2002 J. Immunol. pmid:12444157
Pacheco P et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. 2002 J. Immunol. pmid:12444160
Abe Y et al. Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model. 2002 Eur. J. Pharmacol. pmid:12445578
Marathe GK et al. Activation of vascular cells by PAF-like lipids in oxidized LDL. 2002 Vascul. Pharmacol. pmid:12449015
Lacombe J et al. Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides. 2002 Can. J. Physiol. Pharmacol. pmid:12450061
Francescangeli E et al. Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei. 2002 Neurochem. Res. pmid:12512951
Roy Baker R and Chang Hy MgATP may depress de novo neuronal nuclear PAF generation by promoting the formation of alkylacylglycerophosphate, an inhibitor of alkylglycerophosphate acetyltransferase. 2002 Biochim. Biophys. Acta pmid:12457714
Pan YH et al. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive. 2002 Biochemistry pmid:12475227
Smith JM et al. Platelet-activating factor and Escherichia coliO157:H7 infections. 2002 Pediatr. Nephrol. pmid:12478356
Makhija R and Kingsnorth AN Cytokine storm in acute pancreatitis. 2002 J Hepatobiliary Pancreat Surg pmid:12483260
Lee YM et al. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. 2002 J. Lab. Clin. Med. pmid:12434132
Abu-Zidan FM and Windsor JA Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. 2002 Eur J Surg pmid:12440758
Ryan KL et al. Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating. 2002 Methods Find Exp Clin Pharmacol pmid:12168504
Takizawa T et al. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. 2002 J. Allergy Clin. Immunol. pmid:12170264
Sun Z et al. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. 2002 J. Surg. Res. pmid:12121711
Mayer K et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12124231
Giorgi G et al. Mass spectrometric characterization of substituted 2-thiazolin-4-one derivatives. 2002 J Mass Spectrom pmid:12125004
Kulikov VI and Muzya GI Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals. 2002 Biochemistry Mosc. pmid:12126473
Leusch A et al. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. 2002 Eur J Pharm Sci pmid:12128165
Megens AA et al. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. 2002 J. Pharmacol. Exp. Ther. pmid:12130734
Podolak-Dawidziak M [Role of white cells and neoplastic cells in haemostasis]. 2002 Pol. Arch. Med. Wewn. pmid:12189915
Strømgaard K et al. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation. 2002 J. Med. Chem. pmid:12190325
Wong RK et al. Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress. 2002 Diabetes pmid:12196480
Goldring WP and Pattenden G A total synthesis of phomactin A. 2002 Chem. Commun. (Camb.) pmid:12196974
Fujiu T et al. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors. 2002 Ann. Allergy Asthma Immunol. pmid:12141728
Bazan NG et al. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. 2002 Prog. Brain Res. pmid:12143339
McLennan SV et al. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. 2002 Diabetes pmid:12145178
Lloberas N et al. The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. 2002 Transplant. Proc. pmid:11959179
Castellvi J et al. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. 2002 Transplant. Proc. pmid:11959181
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Börjesson A et al. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. 2002 Dig Liver Dis pmid:11990391
Borgquist JD et al. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. 2002 J. Leukoc. Biol. pmid:11994500
Kalkanci A et al. The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis. 2002 Mycoses pmid:12000505
Bernatchez PN et al. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. 2002 J. Cell. Biochem. pmid:11968003
Hostettler ME et al. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. 2002 Glia pmid:11968060
Boisfer E et al. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. 2002 J. Lipid Res. pmid:11971944
Steel HC and Anderson R Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. 2002 Br. J. Pharmacol. pmid:11976271
McKay CJ Recent developments in the management of acute pancreatitis. 2002 Dig Surg pmid:11979001
Roudebush WE et al. Embryonic platelet-activating factor: an indicator of embryo viability. 2002 Hum. Reprod. pmid:11980756
Hostettler ME and Carlson SL PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. 2002 Neuroreport pmid:11924887
Barletta E et al. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. 2002 Biol. Chem. pmid:11928813
Larrucea S et al. Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. 2002 Blood pmid:11929771
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Yoshida H et al. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. 2002 Brain Res. pmid:12106666
Jaracz S et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. 2002 J. Org. Chem. pmid:12076171
Downing SJ et al. Effect of inflammatory mediators on the physiology of the human Fallopian tube. 2002 Hum Fertil (Camb) pmid:12082208
Honda Z et al. Platelet-activating factor receptor. 2002 J. Biochem. pmid:12038971
Lloberas N et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. 2002 FASEB J. pmid:12039876
Iatrou C et al. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane? 2002 Nephron pmid:12021524
Acuña AA et al. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. 2002 Eur. Respir. J. pmid:12030727
Steel HC et al. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. 2002 APMIS pmid:12064871
Yoshikawa M et al. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. 2002 Int. Arch. Allergy Immunol. pmid:12065903
Nakamura T et al. Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis. 2002 Dis. Colon Rectum pmid:12068200
Silva-Neto MA et al. Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. 2002 Biochem. Biophys. Res. Commun. pmid:12054663
Kingston JK et al. Effects of formaldehyde fixation on equine platelets using flow cytometric methods to evaluate markers of platelet activation. 2002 Am. J. Vet. Res. pmid:12061530
Zhou ZG and Chen YD Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. 2002 World J. Gastroenterol. pmid:12046059
Kato T et al. Mitochondrial calcium response in human transformed lymphoblastoid cells. 2002 Life Sci. pmid:12052442
Christie PE and Henderson WR Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. 2002 Clin Allergy Immunol pmid:11577541
Arai H Platelet-activating factor acetylhydrolase. 2002 Prostaglandins Other Lipid Mediat. pmid:12432911
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Gélinas DS et al. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. 2002 Br. J. Pharmacol. pmid:12429574
Mahmoud FF et al. In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. 2002 Transplant. Proc. pmid:12431672
Bussolati B et al. Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. 2002 Int. J. Cancer pmid:12209602
Cadwallader KA et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. 2002 J. Immunol. pmid:12218155
Bussolati B et al. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes. 2002 Kidney Int. pmid:12234302
Weyrich AS et al. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. 2002 Circulation pmid:12234942
Han SJ et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). 2002 J. Biol. Chem. pmid:12235132
Akai T et al. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. 2002 J. Neurooncol. pmid:12241114
Ibe BO et al. Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells. Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. 2002 Mol. Genet. Metab. pmid:12409272
Childs EW et al. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. 2002 Shock pmid:12412620
Eikelboom JW et al. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. 2002 Eur. Heart J. pmid:12419297
Tanaka S and Koike T Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia. 2002 Glia pmid:12420315
Cuschieri J et al. Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. 2002 Surgery pmid:12219006
Kato M et al. Platelet-activating factor activates two distinct effector pathways in human eosinophils. 2002 J. Immunol. pmid:12391244
Ueno H et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. 2002 Crit. Care Med. pmid:12394951
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Ichinowatari G et al. Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6. 2002 Eur. J. Pharmacol. pmid:11779582
Willoughby S et al. Platelets and cardiovascular disease. 2002 Eur J Cardiovasc Nurs pmid:14622657
Schwartzkopff F et al. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. 2002 J. Interferon Cytokine Res. pmid:11911809
Royal SJ et al. Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. 2002 Brain Res. pmid:11911856
Ko HM et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. 2002 Cancer Res. pmid:11912159
Ishiguro K et al. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. 2002 Planta Med. pmid:11914965
Barabé F et al. Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. 2002 J. Biol. Chem. pmid:11839753
Mio T et al. Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels. 2002 J. Lab. Clin. Med. pmid:11873241
Klein A et al. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. 2002 Br. J. Pharmacol. pmid:11877329
Bulger EM et al. The macrophage response to endotoxin requires platelet activating factor. 2002 Shock pmid:11900334
Mitsuoka H et al. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. 2002 Shock pmid:11900339
Kondratskaya EL et al. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. 2002 Neurochem. Int. pmid:11900860
Hu G et al. Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels. 2002 Anesth. Analg. pmid:11916783
Ozgün H et al. Lexipafant inhibits postsurgical adhesion formation. 2002 J. Surg. Res. pmid:11922727
Cellai C et al. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. 2002 FASEB J. pmid:11923217
Rivera A et al. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. 2002 Blood pmid:11756192
Chmiel B [The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro]. 2002 Wiad. Lek. pmid:12715347
Furukawa M et al. Presence of platelet-activating factor in nasal polyps and eosinophils. 2002 Acta Otolaryngol. pmid:12542208
Farmer PJ et al. Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. 2002 Inflammation pmid:12546134
Tselepis AD and John Chapman M Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. 2002 Atheroscler Suppl pmid:12573364
Claing A et al. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. 2002 Br. J. Pharmacol. pmid:11815379